300401.SZ Stock Analysis
30
Avoid
Based on Eyestock quantitative analysis, 300401.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Zhejiang Garden Bio-chemical High-tech Co., Ltd. engages in the operation of vitamin D3, and pharmaceutical manufacturing businesses. The company is headquartered in Jinhua, Zhejiang and currently employs 742 full-time employees. The company went IPO on 2014-10-09. The firm's main products include vitamin D3, 25-hydroxy vitamin D3, NF grade cholesterol and refined lanolin. The firm is also engaged in the research and development, production and sales of chemical preparations. The firm distributes its products in the domestic market and to overseas markets.